Name: Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (Tandem scFv-Fc)
SKU: BSFVF-040
Rating: 5 (1 reviews)

Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-CD19/CD28 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD19 & CD28

Type

Tandem scFv-Fc

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma; Follicular lymphoma; Leukemia

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

CD19

Gene ID

930

UniProt ID

P15391

Alternative Names

CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4

Target 2

CD28

Gene ID

940

UniProt ID

P10747

Alternative Names

CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-040). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-040)

Specifications

Targets

Customer Reviews and Q&As